Actively Recruiting
Testing the Melanin-Adjusted Blood Oxygen Sensor MABOS Device Accuracy in Intensive Care Units for Patients with Hypoxemia
Led by University of North Carolina, Chapel Hill · Updated on 2026-09-02
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the accuracy of a new pulse oximeter called the Melanin-Adjusted Blood Oxygen Sensor MABOS in adults admitted to intensive care units. The study focuses on how well this device measures blood oxygen levels across a wide range of skin pigmentations and oxygen saturations, aiming to improve oxygen monitoring accuracy for patients of color in critical care settings. Participants will have their skin tone measured on each finger using a spectrophotometer. They will wear the MABOS device on one finger of each hand, as well as a variant of the device on an additional finger and the outer side of the associated wrist. Data will be continuously collected from these devices during the study, which lasts up to 24 hours or until four arterial blood gas tests are completed. During the study, participants will be monitored with the pulse oximeters while their skin pigmentation is assessed. The research team will compare the MABOS oxygen saturation readings to arterial blood gas measurements to assess accuracy. They will also evaluate how well the device estimates melanin concentration and compare its performance to existing pulse oximeters. Participants will be involved for up to 24 hours, with no long-term follow-up mentioned.
CONDITIONS
Brief Title
Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings
Research Team
A
Arjun Putcha, M.S.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here